| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692524 | The Breast | 2017 | 6 Pages |
Abstract
The CDR and FP rate of surveillance MRI in this study were comparable to those reported for women with BRCA mutations. The addition of annual MRI to mammography should be considered for surveillance of women with a combination of these risk factors, particularly if they have a family history of BC and are not on anti-estrogen therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Michelle BScH, MD, Hyder (Clinical Lecturer, Radiologist), Ellen MD, MSc, FRCPC, FACP, Anne L. PhD, Sharmila BSc, Liying PhD, Joseph H. BA, Belinda (Assistant Professor, Radiologist),